cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma

Huseyin Salih SEMIZ; Emel Ebru PALA; Behzat CAN; Elif ATAG; Hatice GUNGOR; Muzaffer SANCI

doi:10.5146/tjpath.2022.01588

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)

Table of Contents

2023, Volume 39, Number 1, Page(s) 055-063

[ Abstract (English) ] [ Full Text (English) ] [ PDF ]

DOI: 10.5146/tjpath.2022.01588

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma

Huseyin Salih SEMIZ¹, Emel Ebru PALA², Behzat CAN³, Elif ATAG⁴, Hatice GUNGOR⁴, Muzaffer SANCI³

¹Department of Medical Oncology, Dokuz Eylül University Institute of Oncology, IZMIR, TURKEY
²Department of Pathology, Health Science University, Tepecik Education and Research Hospital, IZMIR, TURKEY
³Department of Gynecological Oncology, Health Science University, Tepecik Education and Research Hospital, IZMIR, TURKEY
⁴Department of Medical Oncology, Health Science University, Istanbul Haydarpaşa Numune Education and Research Hospital, ISTANBUL, TURKEY

[ Abstract (English) ] [ PDF ]